Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : MRTX crawled time : 19:00 save search
New Late-Breaking Data on Investigational Adagrasib Show Regression of Central Nervous System (CNS) Metastases in Patients with KRASG12C-mutated Non-Small Cell Lung Cancer (NSCLC) with Active, Untreated CNS Metastases
Published: 2022-06-06 (Crawled : 19:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 6.31%
H: 1.07%
C: -2.15%
krasg12 system cancer
Artificial Intelligence Being Used to Accurately Predict Synergistic Cancer Drug Combinations
Published: 2021-12-10 (Crawled : 19:00) - prnewswire.com
BMY | $47.84 -0.87% 0.48% 9.9M
|
Health Technology
| Email alert
Add to watchlist
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
| Email alert
Add to watchlist
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
| Email alert
Add to watchlist
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
| Email alert
Add to watchlist
MRK | $125.37 0.25% 0.44% 4.7M
|
Health Technology
| Email alert
Add to watchlist
artificial intelligence drug cancer drug cancer
Resolution Bioscience Announces Companion Diagnostic Collaboration with Mirati Therapeutics
Published: 2021-01-11 (Crawled : 19:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -1.45%
H: 0.56%
C: -2.22%
collaboration therapeutics bioscience diagnostic
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.